Journals / Atatürk Üniversitesi Veteriner Bilimleri Dergisi / 2020 / Cilt: 15 - Sayı: 2

A Comparison of Urotensin 2 Receptor in Genital System Organs of Prepubertal and Postpubertal Rats

Prepubertal ve Postpubertal Sıçanların Genital Sistem Organlarında Ürotensin 2 Reseptörünün Karşılaştırılması

Pages
113–121
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was concluded that UTR 2 should be investigated in detail in ovarian and uterine diseases and further investigations of ovarian and uterine diseases related to UTR 2 agonists and antagonists should be performed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, we aimed to investigate the presence and distribution of urotensin 2 receptor (UTR 2) in the genital organs (ovary, uterus and testis) before and after puberty as prepubertal and postpubertal.
📊
Key Findings & Data:A total of 20 Wistar Albino rats were used.
💡
Conclusion & Impact:It was concluded that UTR 2 should be investigated in detail in ovarian and uterine diseases and further investigations of ovarian and uterine diseases related to UTR 2 agonists and antagonists should be performed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, we aimed to investigate the presence and distribution of urotensin 2 receptor (UTR 2) in the genital organs (ovary, uterus and testis) before and after puberty as prepubertal and postpubertal. A total of 20 Wistar Albino rats were used. The rats were divided into two groups (N: 5) male (Group 1: prepubertal male, Group 2: postpubertal male) and 2 groups (N: 5) female (Group 3: prepubertal female, Group 4: postpubertal female). Uterine, ovarian and testicular samples were collected from rats. In the molecular study, UTR 2 mRNA expression levels were examined by real-time polymerase chain reaction (Real Time-Polymerase Chain Reaction) and immunohistochemical results were compared with the results of UTR 2 staining. UTR 2 mRNA expression levels in the prepubertal and postpubertal ovary and uterine tissues of female rats were found to be significantly increased in postpubertal, but no difference was seen in UTR 2 mRNA expression levels in testicular tissues of male rats. It was thought that increased UTR 2 levels in the postpubertal ovary and uterus may be associated with increased estrogen or progesterone levels. It was concluded that UTR 2 should be investigated in detail in ovarian and uterine diseases and further investigations of ovarian and uterine diseases related to UTR 2 agonists and antagonists should be performed.

Özet

Çalışmada sıçanlarda genital organlarda (over, uterus ve testis) puberte öncesi ve sonrasında Ürotensin 2 Reseptör’ü (ÜTR2) varlığını ve dağılımını karşılaştırmalı olarak araştırmayı amaçladık. Çalışma toplam 20 adet Wistar Albino cinsi sıçan ileyapıldı. Sıçanlar 2 grup (N:5) erkek (Grup 1: prepubertal erkek, Grup 2: postpubertal erkek) ve 2 grup (N:5) dişi (Grup 3:prepubertal dişi, Grup 4: postpubertal dişi) olmak üzere 4 gruba ayrıldı. Sıçanlardan uterus, over ve testis örnekleri alındı.Moleküler çalışmada ÜTR 2 mRNA ekspresyon seviyeleri gerçek zamanlı polimeraz zincir reaksiyonu) ile incelendi veimmünohistokimyasal olarak ÜTR 2 boyaması ile sonuçlar karşılaştırıp bu dokularda ÜTR 2 varlığı ve dağılımı araştırıldı. Dişisıçanlarda prepubertal ve postpubertal over ve uterus dokularında ÜTR 2 mRNA ekspresyon seviyeleri değerlendirildiğindepostpubertede istatiksel olarak anlamlı oranda artmış olarak bulunurken, erkek sıçanların testis dokularındaki ÜTR 2 mRNAekspresyon seviyelerinde prepuberte ve postpubertede arasında bir fark görülmedi. Postpubertal over ve uterusta artan ÜTR2 seviyelerinin artan östrojen ya da progesteron seviyeleri ile ilişkili olabileceği düşünüldü. Over ve uterus hastalıklarında ÜTR2’ ünün ayrıntılı olarak araştırılması ve ÜTR 2’ü agonist ve antagonistleri ile ilgili over ve uterus hastalıklarında ileri araştırmalaryapılması gerekliliği sonucuna varıldı.

🔖

Cite This Article

HALICI, Z., KÖSE, D., TOKTAY, E. (2022). A Comparison of Urotensin 2 Receptor in Genital System Organs of Prepubertal and Postpubertal Rats. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, Cilt: 15 - Sayı: 2, 113–121. https://ajindex.com/articles/455729

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Vaudry H., Do Rego JC., Le Mevel JC., Chatenet D., Tostivint H., Fournier A., Tonon MC., Pelletier G., Conlon JM., Leprince J., 2010. Urotensin II, from fish to human. Ann N Y Acad Sci, 1200, 53- 66
  2. Huang CY., Burns JC., Shimizu C., 2017. Urotensin 2 in Kawasaki disease pathogenesis. Pediatr Res, 82, 1048-1055
  3. Jumaah S., Celekli A., Sucu M., 2018. The role of human urotensin-II in patients with hypertrophic cardiomyopathy. J Immunoassay Immunochem, 39, 150-162
  4. McDonald J., Batuwangala M., Lambert DG., 2007. Role of urotensin II and its receptor in health and disease. J Anesth, 21, 378-389
  5. Zhang X., Ye Y., Yang C., Gong H., Li Y., Zhang G., Yuan J., Zou Y., 2018. Clinical significance of increased urotensin II levels in acute myocardial infarction. Discov Med, 26, 7-20
  6. Ong KL., Lam KS., Cheung BM., 2005. Urotensin II: its function in health and its role in disease. Cardiovasc Drugs Ther, 19, 65-75
  7. Ames RS., Sarau HM., Chambers JK., Willette RN., Aiyar NV., Romanic AM., Louden CS., Foley JJ., Sauermelch CF., Coatney RW., Ao Z., Disa J., Holmes SD., Stadel JM., Martin JD., Liu WS., Glover GI., Wilson S., McNulty DE., Ellis CE., Elshourbagy NA., Shabon U., Trill JJ., Hay DW., Ohlstein EH., Bergsma DJ., Douglas SA., 1999. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature, 401, 282-286
  8. Song W., Abdel-Razik AE., Lu W., Ao Z., Johns DG., Douglas SA., Balment RJ., Ashton N., 2006. Urotensin II and renal function in the rat. Kidney Int, 69, 1360-1368
  9. Watson AM., Lambert GW., Smith KJ., May CN., 2003. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension, 42, 373-379
  10. Papadopoulos P., Bousette N., Giaid A., 2008. Urotensin-II and cardiovascular remodeling. Peptides, 29, 764-769
  11. Dai HY., Kang WQ., Wang X., Yu XJ., Li ZH., Tang MX., Xu DL., Li CW., Zhang Y., Ge ZM., 2007. The involvement of transforming growth factorbeta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts. Regul Pept, 140, 88-93
  12. Shiraishi Y., Watanabe T., Suguro T., Nagashima M., Kato R., Hongo S., Itabe H., Miyazaki A., Hirano T., Adachi M., 2008. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. J Hypertens, 26, 1955-1965
  13. Guidolin D., Albertin G., Ribatti D., 2010. Urotensin-II as an angiogenic factor. Peptides, 31